![Ron Alfa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Ron Alfa ist Senior Vice President-Forschung bei Recursion Pharmaceuticals, Inc.
| Unternehmen | Position | Beginn |
|---|---|---|
Noetik, Inc.
 Noetik, Inc. Packaged SoftwareTechnology Services Develops AI-powered biotechnology drug products for cancer therapies | Vorstandsvorsitzender | 01.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Noetik, Inc.
Noetik, Inc. Packaged SoftwareTechnology Services Develops AI-powered biotechnology drug products for cancer therapies | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
